Projects per year
Fingerprint
Dive into the research topics where New Jersey Medical School (NJMS), Biochemistry is active. These topic labels come from the works of this organization's members. Together they form a unique fingerprint.
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Profiles
-
Targeting a phosphatidylserine/TAM receptor/PD-L1 axis as a vulnerability in cancer
Birge, R. (CoPI) & Kotenko, S. (CoPI)
2/1/22 → 1/31/26
Project: Research
-
Mitochondrial metabolism and the Lon-PDH axis
Suzuki, C. (CoPI)
National Institute of General Medical Sciences
4/1/20 → 3/31/24
Project: Research
Research output
-
Dys-regulated phosphatidylserine externalization as a cell intrinsic immune escape mechanism in cancer
Pulica, R., Aquib, A., Varsanyi, C., Gadiyar, V., Wang, Z., Frederick, T., Calianese, D. C., Patel, B., de Dios, K. V., Poalasin, V., De Lorenzo, M. S., Kotenko, S. V., Wu, Y., Yang, A., Choudhary, A., Sriram, G. & Birge, R. B., Dec 2025, In: Cell Communication and Signaling. 23, 1, 131.Research output: Contribution to journal › Review article › peer-review
-
TRIM21-mediated ubiquitination of SQSTM1/p62 abolishes its Ser403 phosphorylation and enhances palmitic acid cytotoxicity
Yang, P., Gao, S., Shen, J., Liu, T., Lu, K., Han, X., Wang, J., Ni, H. M., Ding, W. X., Li, H., Pan, J. A., Peng, K. & Zong, W. X., 2025, In: Autophagy. 21, 1, p. 178-190 13 p.Research output: Contribution to journal › Article › peer-review
-
Powering down the mitochondrial LonP1 protease: a novel strategy for anticancer therapeutics
Shetty, R., Noland, R., Nandi, G. & Suzuki, C. K., 2024, In: Expert Opinion on Therapeutic Targets. 28, 1-2, p. 9-15 7 p.Research output: Contribution to journal › Article › peer-review